Position in VNDA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,371,380
+$395,443 QoQ
Shares Held
714,278
+24.1% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. VNDA ranks #72 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
719,905 | $216,713,000 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,785,716 | $198,268,046 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,884 | $160,177,448 | |
| 4 | MRNA |
Moderna, Inc.
|
1,794,778 | $125,688,301 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
749,398 | $85,933,468 | |
| 6 | EYPT |
EyePoint, Inc.
|
5,681,052 | $81,239,042 | |
| 7 | ARGX |
Argenx SE
|
87,288 | $80,983,187 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
3,116,805 | $79,104,510 |
All Filings in VNDA
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,371,380 | 714,278 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $3,975,937 | 575,389 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $4,890,045 | 554,427 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $3,402,360 | 681,836 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $3,438,491 | 728,494 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,336,538 | 726,915 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $3,480,504 | 726,619 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,361,692 | 716,779 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,043,394 | 715,645 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $2,941,403 | 715,670 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,452,073 | 818,027 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $3,894,518 | 901,509 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,816,221 | 1,034,328 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $7,094,035 | 1,044,777 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $5,940,953 | 803,918 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,879,188 | 493,845 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,289,562 | 485,281 | Shares | Defined | 2022-09-16 | |
| 2022-03-31 | $6,090,909 | 538,542 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $8,514,397 | 542,664 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,390,868 | 547,892 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 ALXN | — | 3,915 | Shares | Defined | 2021-08-16 | |
| 2021-06-30 | $11,027,466 | 512,667 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 ALXN | — | 4,951 | Shares | Defined | 2021-05-13 | |
| 2021-03-31 | $7,594,576 | 505,631 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 ALXN | — | 9,647 | Shares | Defined | 2021-02-12 | |
| 2020-12-31 | $6,103,858 | 464,525 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 ALXN | — | 205,800 | Shares | Defined | 2020-11-12 | |
| 2020-09-30 | $4,463,015 | 462,010 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 ALXN | — | 148,282 | Shares | Defined | 2020-08-13 | |
| 2020-06-30 | $2,953,087 | 258,137 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 ALXN | — | 195,432 | Shares | Defined | 2020-05-13 | |
| 2020-03-31 | $2,518,204 | 243,070 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||